Mergers & Acquisitions - Bristol-Myers Squibb, Licensing

Filter

Popular Filters

The Medicines Company in over $105 million deal with Bristol-Myers for Recothrom; buys Incline Thera

14-12-2012

Pharma major Bristol-Myers Squibb (NYSE: BMY) and fellow-USA-based The Medicines Company (Nasdaq: MDCO)…

Bristol-Myers SquibbIncline TherapeuticsIonsysLicensingMergers & AcquisitionsNeurologicalPharmaceuticalRecothromThe Medicines Company

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top